SS
OACCU

Steve Schonfeld’s Oaktree Acquisition Corp III Life Sciences Unit OACCU Stock Holding History

Steve Schonfeld’s Portfolio OACCU Stock Details OACCU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-367,622
Closed -$3.84M – 2663
2025
Q1 		$3.84M Sell
367,622
-473,206
-56% -$4.83M 0.02% 631
2024
Q4 		$8.52M Buy
+840,828
New +$8.47M 0.05% 342

Other funds holding OACCU

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AC
Athos Capital Hong Kong $282M AUM 11.4% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Steve Schonfeld's OACCU Position: Q2 2025 in Review

Steve Schonfeld sold out of Oaktree Acquisition Corp III Life Sciences Unit (OACCU) in Q2 2025, closing a stake of 367,622 shares — an estimated $3.84M sold.

Steve Schonfeld first reported a position in OACCU in Q4 2024 and held it in 2 quarters. The position peaked at $8.52M in Q4 2024. 6 funds tracked by Wall St. Rank hold OACCU as of Q2 2025.

  • Steve Schonfeld reported no remaining Oaktree Acquisition Corp III Life Sciences Unit position as of Q2 2025 after selling out during the quarter.
  • Steve Schonfeld sold 367,622 Oaktree Acquisition Corp III Life Sciences Unit shares in Q2 2025, an estimated $3.84M.
  • Steve Schonfeld first reported a position in Oaktree Acquisition Corp III Life Sciences Unit in Q4 2024 and held it in 2 quarters.
  • Steve Schonfeld's Oaktree Acquisition Corp III Life Sciences Unit position peaked at $8.52M in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Unit as of Q2 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.